New Two-Pronged weapon tested against tough cancers
NCT ID NCT04868877
Summary
This early-stage study is testing a new drug called MCLA-129, which is designed to attack cancer cells by blocking two different growth signals at once. It is for adults with advanced lung, stomach, head/neck, or other solid tumors that have stopped responding to standard treatments. The main goals are to find the safest and most effective dose and to see if the drug can shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ASST Grande Ospedale Metropolitano Niguarda
Milan, 22162, Italy
-
ASST degli Spedali Civili di Brescia
Brescia, 25123, Italy
-
Antwerp University Hospital
Edegem, 2650, Belgium
-
Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento
Verona, 37126, Italy
-
Azienda Ospedaliera Universitaria San Giovanni di Dio e Ruggi d'Aragona
Salerno, 84131, Italy
-
Azienda Ospedaliero - Universitaria San Luigi Gonzaga
Orbassano, 10043, Italy
-
Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi
Bologna, 40138, Italy
-
CHU Hopitaux de Bordeaux - Hôpital Saint-André
Bordeaux, 33000, France
-
CHU de Lyon - Louis Pradel Hospital
Bron, 69677, France
-
CHU de Nantes - Hôpital Nord Laennec
Nantes, 44093, France
-
CHU de Poitiers
Poitiers, 86000, France
-
Centre Hospitalier Intercommunal de Créteil
Créteil, 94010, France
-
Centro Integral Oncológico Clara Campal
Madrid, 28050, Spain
-
Clinique de l'Europe
Amiens, 80090, France
-
Clínica Universidad de Navarra
Pamplona, 31008, Spain
-
Clínica Universidad de Navarra -Madrid
Madrid, 28027, Spain
-
Erasmus Medical Center
Rotterdam, Netherlands
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, 20133, Italy
-
Fundación Instituto Valenciano de Oncología (IVO)
Valencia, 46009, Spain
-
Gachon University Gil Hospital
Incheon, 21565, South Korea
-
Hospital General Universitario Gregorio Marañón
Madrid, 28007, Spain
-
Hospital HM Delfos
Barcelona, 08023, Spain
-
Hospital Quirón Madrid
Madrid, 28223, Spain
-
Hospital Universitari i Politècnic La Fe
Valencia, 46026, Spain
-
Hospital Universitario 12 de Octubre
Madrid, 28041, Spain
-
Hospital Universitario Fundacion Jimenez Diaz
Madrid, 28040, Spain
-
Hospital Universitario Vall d'Hebron
Barcelona, 08035, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08025, Spain
-
Hôpital Albert Calmette
Lille, 59037, France
-
Hôpital Bichat - Claude-Bernard
Paris, 75877, France
-
Hôpital Européen Georges Pompidou (HEGP)
Paris, 75908, France
-
Hôpital d'Instruction des Armées Bégin
Saint-Mandé, 94163, France
-
IOB Institute of Oncology - Hospital Quironsalud Barcelona
Barcelona, 8023, Spain
-
Institut Jules Bordet
Anderlecht, Belgium
-
Istituto Nazionale dei Tumori Regina Elena
Roma, Rome, 00144, Italy
-
Krankenhaus Nordwest
Frankfurt am Main, Hesse, 60488, Germany
-
L'Institut Paoli - Calmettes
Marseille, 13009, France
-
Marie Wislez
Paris, 75014, France
-
National Cancer Centre of Singapore
Singapore, 169610, Singapore
-
Netherlands Cancer Institute
Amsterdam, Netherlands
-
Next Oncology Virginia
Fairfax, Virginia, 22031, United States
-
START Mountain Region
West Valley City, Utah, 84119, United States
-
Samsung Medical Center
Seoul, 6351, South Korea
-
Sana Klinikum Offenbach GmbH
Offenbach, 63069, Germany
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Seoul National University Hospital
Seoul, South Korea
-
Severance Hospital - Yonsei Cancer Center
Seoul, South Korea
-
The Catholic University of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
-
The Catholic University of Korea, St. Vincent's Hospital
Suwon, Gyeonggi-do, 16247, South Korea
-
University Medical Center Groningen
Groningen, Netherlands
-
University of California, Irvine
Orange, California, 92868, United States
Conditions
Explore the condition pages connected to this study.